Latest News About Rsv Vaccinations

Here are the latest high-level updates on RSV vaccinations:

• The CDC and FDA have continued expanding and refining recommendations for RSV vaccines, focusing on adults 60 and older, with some updates to include those 50–59 at higher risk and pregnant individuals for infant protection. This broadens eligibility beyond the initial older adult focus.[1][2]
• Safety monitoring remains a priority; officials have discussed rare but notable risks such as Guillain-Barré syndrome, and guidance emphasizes informing recipients about these small risks while highlighting substantial protection against severe RSV disease.[1]
• Availability and coverage have been moving forward, with vaccines from major manufacturers (e.g., Arexvy and Abrysvo) becoming more widely used and eligible for insurance reimbursement in many jurisdictions.[2][4]

What this means for you in São Paulo, Brazil:

• RSV vaccines are still primarily targeted to high-risk groups in many countries; local guidelines may differ from U.S. recommendations. If you’re considering vaccination for yourself or a family member, check with Brazil’s health authorities (Ministério da Saúde) or your local health clinic for current Brazilian guidance, eligibility, and availability. [general guidance]

If you’d like, I can search for Brazil-specific RSV vaccine updates and translate the latest official guidance into Portuguese, with links to local resources.